A Study of Survival and Outcome After Stroke
NCT01193569 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142
Last updated 2018-04-12
Summary
The objective of this study is to determine the natural history of acute ischemic stroke from large vessel thromboembolism in the brain. The target population is a stroke cohort with a known infarct volume who presents within 8 hours from symptom onset with a NIH Stroke Scale (NIHSS) score \>10 who are eligible for mechanical thrombectomy but without receiving the treatment. Functional outcome as defined by the modified Rankin Scale (mRS) of all enrolled patients will be followed for 90 days after the index event.
Conditions
Sponsors & Collaborators
-
Penumbra Inc.
lead INDUSTRY
Principal Investigators
-
Iris Q Grunwald, MD · The John Radcliffe Hospital, Oxford, UK
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2016-12-22
- Completion
- 2016-12-22
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).
NCT07107022 ·Status: RECRUITING
-
Dapsone for Acute Ischemia Stroke Study
NCT01144650 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
NCT05955326 ·Status: RECRUITING ·Phase: PHASE4
-
Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke
NCT06559436 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke
NCT01133223 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Siblings With Ischemic Stroke Study
NCT00108940 ·Status: COMPLETED
-
Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
NCT05630586 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
NCT07030621 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
NCT00790920 ·Status: COMPLETED ·Phase: PHASE3
-
Safe Implementation of Thrombolysis in Stroke - Monitoring Study
NCT02229812 ·Status: COMPLETED
-
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
NCT00046761 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
NCT04962503 ·Status: COMPLETED ·Phase: PHASE2
-
TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion
NCT01654445 ·Status: COMPLETED ·Phase: PHASE2
-
Thrombolysis Outcome in Ischemic Stroke
NCT04309357 ·Status: COMPLETED
-
Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
NCT03329365 ·Status: ACTIVE_NOT_RECRUITING
-
Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT
NCT05199662 ·Status: RECRUITING ·Phase: PHASE3
-
Stroke Ready - Optimizing Acute Stroke Care
NCT03645590 ·Status: COMPLETED ·Phase: NA
-
Interventional Management of Stroke (IMS) II Study
NCT00243906 ·Status: COMPLETED ·Phase: PHASE2
-
Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
NCT06052969 ·Status: RECRUITING ·Phase: NA
-
Non-immunogenic Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
NCT05697575 ·Status: RECRUITING
-
An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke
NCT02229890 ·Status: COMPLETED
-
Study for the Use of Alteplase in Patients Who Awaken With Stroke
NCT01150266 ·Status: WITHDRAWN ·Phase: PHASE1
-
Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke
NCT02178657 ·Status: COMPLETED ·Phase: PHASE2
-
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial
NCT05172934 ·Status: COMPLETED ·Phase: PHASE2